These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 632628)

  • 21. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
    Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assay for anti-rubella hemagglutination-inhibiting antibodies in a homogenous sample of a school-age population from the community of Montepulciano (Siena). Considerations on its relation to the vaccination policy in Tuscany].
    Santi MT; Biagi P; Baricci P; Valdambrini L; Milani G
    Ann Sclavo; 1982; 24(4):423-8. PubMed ID: 7187209
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problems of rubella prevention: vaccination of 51 fertile young women with the Wister Ra 27/3 virus strain].
    Russo F; Piro E; Frugiuele PL; Buffone E; Palma B; Greco LM
    Ann Sclavo; 1980; 22(1):57-62. PubMed ID: 7247485
    [No Abstract]   [Full Text] [Related]  

  • 25. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rubella prophylactic immunization problems in the Czechoslovak SSR: experiences with Ra 2713 and Cendehill rubella vaccines].
    Strauss J; Vodićková M; Domorázková E
    Z Gesamte Hyg; 1980; 26(5):360-2. PubMed ID: 7467541
    [No Abstract]   [Full Text] [Related]  

  • 27. Trial of high-titre human rubella immunoglobulin.
    Urquhart GE; Crawford RJ; Wallace J
    Br Med J; 1978 Nov; 2(6148):1331-2. PubMed ID: 363233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of rubella antibody 8-18 years after vaccination.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1984 Apr; 288(6423):1043. PubMed ID: 6423188
    [No Abstract]   [Full Text] [Related]  

  • 30. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination.
    Zealley H; Edmond E
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):382-4. PubMed ID: 6800467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
    Ehrengut W; Florent G
    Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rubella: who needs a blood test?
    Lancet; 1979 Jun; 1(8130):1329-31. PubMed ID: 87785
    [No Abstract]   [Full Text] [Related]  

  • 38. Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes.
    Sugishita C; O'Shea S; Best JM; Banatvala JE
    Clin Exp Immunol; 1978 Jan; 31(1):50-4. PubMed ID: 639348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.